Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection

BACKGROUND: Neoadjuvant chemotherapy (NC) is an established therapy in breast cancer, able to downstage positive axillary lymph nodes, but might hamper their detectibility. Even if clinical observations suggest lower lymph node yield (LNY) after NC, data are inconclusive and it is unclear whether NC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Erbes, Thalia, Orlowska-Volk, Marzenna, zur Hausen, Axel, Rücker, Gerta, Mayer, Sebastian, Voigt, Matthias, Farthmann, Juliane, Iborra, Severine, Hirschfeld, Marc, Meyer, Philipp T, Gitsch, Gerald, Stickeler, Elmar
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3884010/
https://ncbi.nlm.nih.gov/pubmed/24386929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados